Will Chevron Acquire Hess?
Long-time Buffett favorite in the energy sector Chevron (NYSE:CVX) is…
Buy
60
ALNY Quote, Financials, Valuation and Earnings
Last price:
$280.77
Seasonality move
:
3.3%
Day range:
$287.77 - $300.90
52-week range:
$141.98 - $304.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
16.50x
P/B ratio:
560.95x
Volume:
1.8M
Avg. volume:
849.4K
1-year change:
98.42%
Market cap:
$37.6B
Revenue:
$2.2B
EPS (TTM):
-$2.17
ALNY Analysts' Consensus Rating
The 20 analysts providing 12-month price projections for Alnylam Pharmaceuticals shares anticipate an average target of $311.24, ranging from a low estimate of $206.00 to a high estimate of $500.00. This average target implies a growth of 7.07% compared to the current stock price of $290.70.
Consensus Price Target
$311.24
Highest Price Target
$500.00
Lowest Price Target
$206.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 11 | 11 | 11 |
| Hold | 8 | 8 | 8 |
| Sell | 0 | 1 | 1 |
| Consensus | Buy | Buy | Buy |
ALNY Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Progressive Stock Go Down?
Shares of insurance giant Progressive (NYSE:PGR) have fallen considerably over…
Why Did StoneCo Stock Go Up So Much?
Brazilian fintech company StoneCo (NASDAQ:STNE) has been on a tear…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
47
RGC alert for Mar 25
Regencell Bioscience Holdings [RGC] is up 4.9% over the past day.
Buy
54
AZEK alert for Mar 25
The AZEK [AZEK] is up 1.01% over the past day.
Sell
36
MPTI alert for Mar 25
M-Tron Industries [MPTI] is up 7.48% over the past day.
